238 related articles for article (PubMed ID: 38699289)
1. Use of the Chinese version of the MATRICS Consensus Cognitive Battery to assess cognitive functioning in individuals with high risk for psychosis, first-episode schizophrenia and chronic schizophrenia: a systematic review and meta-analysis.
Cai B; Zhu Y; Liu D; Li Y; Bueber M; Yang X; Luo G; Su Y; Grivel MM; Yang LH; Qian M; Stone WS; Phillips MR
Lancet Reg Health West Pac; 2024 Apr; 45():101016. PubMed ID: 38699289
[TBL] [Abstract][Full Text] [Related]
2. Cognitive deficits profiles in the first-episode of schizophrenia, clinical high risk of psychosis, and genetically high-risk of psychosis.
Dong F; Mao Z; Ding Y; Wang L; Bo Q; Li F; Wang F; Wang C
Front Psychiatry; 2023; 14():1292141. PubMed ID: 38146278
[TBL] [Abstract][Full Text] [Related]
3. Meta-analysis of cognitive function in Chinese first-episode schizophrenia: MATRICS Consensus Cognitive Battery (MCCB) profile of impairment.
Zhang H; Wang Y; Hu Y; Zhu Y; Zhang T; Wang J; Ma K; Shi C; Yu X; Li C
Gen Psychiatr; 2019; 32(3):e100043. PubMed ID: 31423473
[TBL] [Abstract][Full Text] [Related]
4. Dysfunction of Cognition Patterns Measured by MATRICS Consensus Cognitive Battery (MCCB) among First Episode Schizophrenia Patients and Their Biological Parents.
Cao A; Shen T; Li H; Wu C; McCabe M; Mellor D; Byrne L; Zhang J; Huang J; Peng D; Xu Y
Shanghai Arch Psychiatry; 2017 Jun; 29(3):154-160. PubMed ID: 28904510
[TBL] [Abstract][Full Text] [Related]
5. Cognitive functioning in first-episode schizophrenia: MATRICS Consensus Cognitive Battery (MCCB) Profile of Impairment.
McCleery A; Ventura J; Kern RS; Subotnik KL; Gretchen-Doorly D; Green MF; Hellemann GS; Nuechterlein KH
Schizophr Res; 2014 Aug; 157(1-3):33-9. PubMed ID: 24888526
[TBL] [Abstract][Full Text] [Related]
6. Longitudinal changes in cognitive function in early psychosis: a meta-analysis with the MATRICS consensus cognitive battery (MCCB).
Ding Y; Hou W; Wang C; Sha S; Dong F; Li X; Wang N; Lam ST; Zhou F; Wang C
Schizophr Res; 2024 Jul; 270():349-357. PubMed ID: 38968806
[TBL] [Abstract][Full Text] [Related]
7. Profile of cognitive deficits in schizophrenia and factor structure of the Czech MATRICS Consensus Cognitive Battery.
Bezdicek O; Michalec J; Kališová L; Kufa T; Děchtěrenko F; Chlebovcová M; Havlík F; Green MF; Nuechterlein KH
Schizophr Res; 2020 Apr; 218():85-92. PubMed ID: 32089475
[TBL] [Abstract][Full Text] [Related]
8. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
9. Healthy adolescent performance on the MATRICS Consensus Cognitive Battery (MCCB): Developmental data from two samples of volunteers.
Stone WS; Mesholam-Gately RI; Giuliano AJ; Woodberry KA; Addington J; Bearden CE; Cadenhead KS; Cannon TD; Cornblatt BA; Mathalon DH; McGlashan TH; Perkins DO; Tsuang MT; Walker EF; Woods SW; McCarley RW; Heinssen R; Green MF; Nuechterlein K; Seidman LJ
Schizophr Res; 2016 Apr; 172(1-3):106-13. PubMed ID: 26896388
[TBL] [Abstract][Full Text] [Related]
10. Neurocognitive dysfunction in subjects at clinical high risk for psychosis: A meta-analysis.
Zheng W; Zhang QE; Cai DB; Ng CH; Ungvari GS; Ning YP; Xiang YT
J Psychiatr Res; 2018 Aug; 103():38-45. PubMed ID: 29772485
[TBL] [Abstract][Full Text] [Related]
11. The Relationship between Cognitive Functions and Psychopathological Symptoms in First Episode Psychosis and Chronic Schizophrenia.
Rek-Owodziń K; Tyburski E; Plichta P; Waszczuk K; Bielecki M; Wietrzyński K; Podwalski P; Rudkowski K; Michalczyk A; Grąźlewski T; Sagan L; Kucharska-Mazur J; Samochowiec J; Mak M
J Clin Med; 2022 May; 11(9):. PubMed ID: 35566742
[TBL] [Abstract][Full Text] [Related]
12. The association of cognitive impairment with quality of life and functional impairment in Ugandan first-episode psychosis patients: a cross sectional study.
Mwesiga EK; Ssemata AS; Gumikiriza J; Nanteza A; Nakitende AJ; Nakku J; Akena D; Nakasujja N
Health Qual Life Outcomes; 2022 Jul; 20(1):113. PubMed ID: 35870969
[TBL] [Abstract][Full Text] [Related]
13. Familial aggregation of MATRICS Consensus Cognitive Battery scores in a large sample of outpatients with schizophrenia and their unaffected relatives.
Mucci A; Galderisi S; Green MF; Nuechterlein K; Rucci P; Gibertoni D; Rossi A; Rocca P; Bertolino A; Bucci P; Hellemann G; Spisto M; Palumbo D; Aguglia E; Amodeo G; Amore M; Bellomo A; Brugnoli R; Carpiniello B; Dell'Osso L; Di Fabio F; di Giannantonio M; Di Lorenzo G; Marchesi C; Monteleone P; Montemagni C; Oldani L; Romano R; Roncone R; Stratta P; Tenconi E; Vita A; Zeppegno P; Maj M;
Psychol Med; 2018 Jun; 48(8):1359-1366. PubMed ID: 29017620
[TBL] [Abstract][Full Text] [Related]
14. The Polish Academic Version of the MATRICS Consensus Cognitive Battery (MCCB): Evaluation of Psychometric Properties.
Jędrasik-Styła M; Ciołkiewicz A; Styła R; Linke M; Parnowska D; Gruszka A; Denisiuk M; Jarema M; Green MF; Wichniak A
Psychiatr Q; 2015 Sep; 86(3):435-47. PubMed ID: 25601030
[TBL] [Abstract][Full Text] [Related]
15. The MATRICS consensus cognitive battery in patients with bipolar I disorder.
Burdick KE; Goldberg TE; Cornblatt BA; Keefe RS; Gopin CB; Derosse P; Braga RJ; Malhotra AK
Neuropsychopharmacology; 2011 Jul; 36(8):1587-92. PubMed ID: 21451499
[TBL] [Abstract][Full Text] [Related]
16. Cognitive impairments in first-episode drug-naive and chronic medicated schizophrenia: MATRICS consensus cognitive battery in a Chinese Han population.
Wu JQ; Chen DC; Tan YL; Xiu MH; De Yang F; Soares JC; Zhang XY
Psychiatry Res; 2016 Apr; 238():196-202. PubMed ID: 27086233
[TBL] [Abstract][Full Text] [Related]
17. Modafinil for people with schizophrenia or related disorders.
Ortiz-Orendain J; Covarrubias-Castillo SA; Vazquez-Alvarez AO; Castiello-de Obeso S; Arias Quiñones GE; Seegers M; Colunga-Lozano LE
Cochrane Database Syst Rev; 2019 Dec; 12(12):CD008661. PubMed ID: 31828767
[TBL] [Abstract][Full Text] [Related]
18. Use of the MATRICS consensus cognitive battery (MCCB) to evaluate cognitive deficits in bipolar disorder: A systematic review and meta-analysis.
Bo Q; Mao Z; Li X; Wang Z; Wang C; Ma X
PLoS One; 2017; 12(4):e0176212. PubMed ID: 28437438
[TBL] [Abstract][Full Text] [Related]
19. The MCCB impairment profile in a Spanish sample of patients with schizophrenia: Effects of diagnosis, age, and gender on cognitive functioning.
Rodriguez-Jimenez R; Dompablo M; Bagney A; Santabárbara J; Aparicio AI; Torio I; Moreno-Ortega M; Lopez-Anton R; Lobo A; Kern RS; Green MF; Jimenez-Arriero MA; Santos JL; Nuechterlein KH; Palomo T
Schizophr Res; 2015 Dec; 169(1-3):116-120. PubMed ID: 26416441
[TBL] [Abstract][Full Text] [Related]
20. The difference of social cognitive and neurocognitive performance between patients with schizophrenia at different stages and influencing factors.
Chen S; Liu Y; Liu D; Zhang G; Wu X
Schizophr Res Cogn; 2021 Jun; 24():100195. PubMed ID: 33718008
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
